Global PreScission Protease Market Growth 2025-2031
Description
The global PreScission Protease market size is predicted to grow from US$ 157 million in 2025 to US$ 325 million in 2031; it is expected to grow at a CAGR of 13.0% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
PreScission Protease is a fusion protein composed of human rhinovirus (HRV) type 14 3C protease and GST. The protease can specifically recognize the short peptide Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro at low temperature (4°C) and perform enzymatic cleavage between Gln and Gly amino acid residues. The recognition and cleavage of the substrate depends not only on the primary structure of the fusion protein but also on the secondary and tertiary structures of the fusion protein. It can specifically separate the GST tag of the fusion protein with enzyme substrate recognition peptide sequence expressed by vectors such as the pGEX-6P series.
PreScision protease is a new protein degradation technology developed and is an extension of the PROTAC (targeted protein degradation) technology platform. It activates the conditional protease system to achieve precise degradation of targeted proteins in specific tissues or cell environments. In recent years, with the development of precision medicine and protein degradation technology, PreScision protease is gradually becoming a hot spot in drug research and development, especially in the fields of anti-tumor and autoimmune diseases. In the future, its synergistic application with other protein degradation platforms (such as Molecular Glue, LYTAC, etc.) may further promote the diversity and target coverage of targeted drugs.
United States market for PreScission Protease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for PreScission Protease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for PreScission Protease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key PreScission Protease players cover Merck, TriAltus Bioscience, CYTOSKELETON, Genscript, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “PreScission Protease Industry Forecast” looks at past sales and reviews total world PreScission Protease sales in 2024, providing a comprehensive analysis by region and market sector of projected PreScission Protease sales for 2025 through 2031. With PreScission Protease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PreScission Protease industry.
This Insight Report provides a comprehensive analysis of the global PreScission Protease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PreScission Protease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PreScission Protease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PreScission Protease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PreScission Protease.
This report presents a comprehensive overview, market shares, and growth opportunities of PreScission Protease market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity ≥ 95%
Purity < 95%
Segmentation by Application:
Medical Laboratories
University Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
TriAltus Bioscience
CYTOSKELETON
Genscript
Thermo Fisher Scientific
Nucleus Biotech
StemImmune
Beyotime
Yeasen
MedChemExpress
Aurora Biolabs
Novus Biologicals
SBS Genetech
Key Questions Addressed in this Report
What is the 10-year outlook for the global PreScission Protease market?
What factors are driving PreScission Protease market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PreScission Protease market opportunities vary by end market size?
How does PreScission Protease break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
PreScission Protease is a fusion protein composed of human rhinovirus (HRV) type 14 3C protease and GST. The protease can specifically recognize the short peptide Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro at low temperature (4°C) and perform enzymatic cleavage between Gln and Gly amino acid residues. The recognition and cleavage of the substrate depends not only on the primary structure of the fusion protein but also on the secondary and tertiary structures of the fusion protein. It can specifically separate the GST tag of the fusion protein with enzyme substrate recognition peptide sequence expressed by vectors such as the pGEX-6P series.
PreScision protease is a new protein degradation technology developed and is an extension of the PROTAC (targeted protein degradation) technology platform. It activates the conditional protease system to achieve precise degradation of targeted proteins in specific tissues or cell environments. In recent years, with the development of precision medicine and protein degradation technology, PreScision protease is gradually becoming a hot spot in drug research and development, especially in the fields of anti-tumor and autoimmune diseases. In the future, its synergistic application with other protein degradation platforms (such as Molecular Glue, LYTAC, etc.) may further promote the diversity and target coverage of targeted drugs.
United States market for PreScission Protease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for PreScission Protease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for PreScission Protease is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key PreScission Protease players cover Merck, TriAltus Bioscience, CYTOSKELETON, Genscript, Thermo Fisher Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “PreScission Protease Industry Forecast” looks at past sales and reviews total world PreScission Protease sales in 2024, providing a comprehensive analysis by region and market sector of projected PreScission Protease sales for 2025 through 2031. With PreScission Protease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PreScission Protease industry.
This Insight Report provides a comprehensive analysis of the global PreScission Protease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PreScission Protease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PreScission Protease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PreScission Protease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PreScission Protease.
This report presents a comprehensive overview, market shares, and growth opportunities of PreScission Protease market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity ≥ 95%
Purity < 95%
Segmentation by Application:
Medical Laboratories
University Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
TriAltus Bioscience
CYTOSKELETON
Genscript
Thermo Fisher Scientific
Nucleus Biotech
StemImmune
Beyotime
Yeasen
MedChemExpress
Aurora Biolabs
Novus Biologicals
SBS Genetech
Key Questions Addressed in this Report
What is the 10-year outlook for the global PreScission Protease market?
What factors are driving PreScission Protease market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PreScission Protease market opportunities vary by end market size?
How does PreScission Protease break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
122 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for PreScission Protease by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for PreScission Protease by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
